Abstract
While the name amyloid has been used for only 150 years, the history of amyloid goes back several 100 years. The modern history may be said to have started with the characterization of the amyloid as cross beta-sheet structured fibrils. The finding that a number of different proteins can make up the fibrils made a strict nomenclature necessary. The principles of this are described in the chapter.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine. 1975;54:271–99.
Glenner GG. Amyloid deposits and amyloidosis. The β-fibrilloses. N Engl J Med. 1980;302:1283–92 & 1333–43.
Cohen AS. General introduction and a brief history of amyloidosis. In: Marrink J, van Rijswijk MH, editors. amyloidosis. Dordrecht: Martinus Nijhoff Publishers; 1986. p. 3–19.
Sipe JD, Cohen AS. Review: history of the amyloid fibril. J Struct Biol. 2000;130:88–98.
Westermark P. Amyloidosis and amyloid proteins: brief history and definitions. In: Sipe JD, editor. Amyloid proteins The beta sheet conformation and disease. Weinheim: Wiley-VCH; 2005. p. 3–27.
Mandema E, Ruinen L, Scholten H, Cohen AS. Amyloidosis. Amsterdam: Excerpta Medica; 1968.
Wegelius O, Pasternack A. Amyloidosis. London: Academic Press; 1976.
Virchow R. Ueber eine im Gehirn und Ruckenmark des Menschen aufgefunde Substanz mit der chemishen Reaction der Cellulose. Virchows Arch Path Anat. 1854;6:135–8.
Friedreich N, Kekulé A. Zur Amyloidfrage. Virchows Arch Pathol Anat. 1859;16:50–65.
Wild C. Ueber eine im Gehirn und Ruckenmark des Menschen aufgefunde Substanz mit der chemishen Reaction der Cellulose. Beitr path Anat. 1886;1:175–200.
Soyka J. Ueber die amyloide Degeneration. Prag med Wschr. 1876;1:165–71.
Lubarsch O. Zur Kenntnis ungewöhnlicher Amyloidablagerungen. Virchows Arch f Path Anat. 1929;271:867–89.
Vossius A. Ueber amyloide Degeneration der Conjunctiva. Beitr path Anat Allg Path. 1889;4:335–60.
Ostertag B. Demonstration einer eigenartigen familiären “Paramyloidose”. Zentralbl Pathol. 1933;56:253–4.
Andrade C. A peculiar form of peripheral neuropathy: familial atypical generalized amylodosis with special involvement of the peripheral nerves. Brain. 1952;75:408–27.
Costa PP, Figueira AS, Bravo FR. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA. 1978;75:4499–503.
Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun. 1983;116:880–8.
Saraiva MJ. Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies. Expert Rev Mol Med. 2002;4:1–11.
Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid. 2003;10:160–84.
Benson MD, James S, Scott K, Liepnieks JJ, Kluve-Beckerman B. Leucocyte chemotactic factor 2: a novel renal amyloid protein. Kidney Int. 2008;74:218–22.
Cohen AS, Calkins E. Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature. 1959;183:1202–3.
Eanes ED, Glenner GG. X-ray diffraction studies on amyloid filaments. J Histochem Cytochem. 1968;16:673–7.
Divry P, Florkin M. Sur les propriétées optiques de l’amyloide. C R Soc Biol (Paris). 1927;97:1808–10.
Romhányi G. Uber die submikroskopische Struktur des Amyloid. Schweiz Z Pathol (Pathol Microbiol). 1949;12:253–62.
Benditt EP, Eriksen N. Chemical classes of amyloid substance. Am J Pathol. 1971;65:231–52.
Benditt EP, Eriksen N, Hermodson MA, Ericsson LH. The major proteins of human and monkey amyloid substance: common properties including unusual N-terminal amino acid sequences. FEBS Lett. 1971;19:169–73.
Glenner GG, Terry W, Harada M, Isersky C, Page D. Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analysis. Science. 1971;172:1150–1.
Sletten K, Westermark P, Natvig JB. Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med. 1976;143:993–8.
Bennhold H. Eine specifische Amyloidfärbung mit Kongorot. Munch Med Wochenschr. 1922;69:1537–8.
Steensma DP. “Congo” red out of Africa? Arch Path Lab Med. 2001;125:250–2.
Bennhold H. Über die Asscheidung intravenös einverbleibten Kongorotes bei den verschiedensten Erkrankungen insbesondere bei Amyloidosis. Deutsch Arch f klin Med. 1923;142:32–46.
Morgan WKC, Mules JE. The intravenous congo red test: a description of some unrecognized fallacies with suggested improvements. Am J Med Sci. 1960;239:61–70.
Ouchi E, Nomura N, Watabe S, Seiji K, Sato J, Gonai T, Miura K, Yamagata S. Clinical significance of congo red test. Tohoku J Exp Med. 1976;118(suppl):191–8.
Patra S, Jhala CI, Patra BS. Intravenous congo red test in pulmonary tuberculosis for detection of amyloidosis, its value and limitations. J Assoc Physicians India. 1976;24:553–7.
Afkhami A, Moosavi A. Adsorptive removal of congo red, a carcinogenic textile dye, from aqueous solutions by maghemite nanoparticles. J Hazard Mater. 2010;174:398–403.
Griesbach H. Weitere Untersuchungen über Azofarbstoffe behufs Tinction menchlischer und thierischer Gewebe. Zeitschr Wissenschaft MikroskopMicroskop Tech. 1886;3:358–85.
Symmers WSC. Primary amyloidosis: a review. J Clin Pathol. 1956;9:187–211.
Gafni J, Sohar E. Rectal biopsy for the diagnosis of amyloidosis. Am J Med Sci. 1960;240:332–6.
Editorial. (1963) Clinical diagnosis of amyloidosis. J Am Med Assoc 183, 1104.
Westermark P, Stenkvist B. A new method for the diagnosis of systemic amyloidosis. Arch Intern Med. 1973;132:522–3.
Hawkins PN, Richardson S, MacSweeney JE, King AD, Vigushin DM, Lavender JP, Pepys MB. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression. Quart J Med. 1993;86:365–74.
Gellerstedt N. Die elektive, insuläre (Para-)Amyloidose der Bauchspeicheldrüse. zugleich en Beitrag zur Kenntnis der “senilen Amyloidose”. Beitr Path Anat. 1938;101:1–13.
Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P. Amyloid fibril protein nomenclature: 2010 recommendations of the nomenclature committee of the International Society of amyloidosis. Amyloid. 2010;17:101–4.
Acknowledgments
Supported by the Swedish Research Council.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Businees Media, LLC
About this chapter
Cite this chapter
Westermark, P. (2012). Aspects of the History and Nomenclature of Amyloid and Amyloidosis. In: Picken MD, PhD, FASN, M., Dogan, M.D., Ph.D., A., Herrera, M.D., G. (eds) Amyloid and Related Disorders. Current Clinical Pathology. Humana Press. https://doi.org/10.1007/978-1-60761-389-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-60761-389-3_1
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-388-6
Online ISBN: 978-1-60761-389-3
eBook Packages: MedicineMedicine (R0)